收藏切换
The effect of atosiban on premature rupture of membranes in threatened preterm birth and its influence on placental blood perfusion and maternal and infant outcomes
收藏切换
Jing HUA, Jingxi LIU, Qinling MA, Songxiang ZHONG, Jianlan ZHENG*
World Clinical Drug | 2025, 46(5) : 471 - 475
Less
收藏切换
World Clinical Drug | 2025, 46(5): 471-475
• Article •
The effect of atosiban on premature rupture of membranes in threatened preterm birth and its influence on placental blood perfusion and maternal and infant outcomes
Full
Jing HUA, Jingxi LIU, Qinling MA, Songxiang ZHONG, Jianlan ZHENG*
Affiliations
  • Department of Obstetrics, the 73rd Group Military Hospital of the Chinese People's Liberation Army, Xiamen 361001, Fujian Province, China
Published: 2025-05-10 doi: 10.13683/j.wph.2025.05.008
Outline
收藏切换
Objective

To explore the effect of atosiban in the treatment of premature rupture of membranes in threatened preterm birth and its influence on placental blood perfusion and maternal and infant outcomes.

Methods

A total of 103 patients with premature rupture of membranes in threatened preterm birth in our hospital from September 2022 to August 2024 were selected and randomly divided into the study group (n=52, treated with atosiban) and the control group (n=51, treated with ritodrine hydrochloride). The clinical efficacy, placental blood perfusion, maternal and infant outcomes, symptom disappearance time, pregnancy prolongation time and the occurrence of adverse reactions were compared between the two groups.

Results

After treatment, there was a significant difference in the total effective rate between the two groups (92.31% vs. 78.43%, P<0.05). The vascularization-blood flow index, flow index, placental vascularization index, neonatal asphyxia, fetal distress, amniotic fluid fecal contamination, incidence of maternal and infant adverse outcomes, and symptom disappearance time in the study group were all lower than those in the control group (P<0.05). The gestation time of the study group was longer than that of the control group (P<0.05). There was no significant difference in the occurrence of adverse reactions between the two groups (P>0.05).

Conclusion

The application of atosiban in premature rupture of membranes in threatened preterm birth has a better effect. It can assist in stabilizing placental blood perfusion, improve maternal and infant outcomes, and enhance pregnancy safety.

atosiban  /  premature rupture of membranes in threatened preterm birth  /  placental blood perfusion  /  maternal and infant outcomes
华静, 刘景兮, 马钦玲, 钟松香, 郑剑兰. 阿托西班对先兆早产胎膜早破效果及对胎盘血流灌注及母婴结局的影响. 世界临床药物, 2025 , 46 (5) : 471 -475 . DOI: 10.13683/j.wph.2025.05.008
Jing HUA, Jingxi LIU, Qinling MA, Songxiang ZHONG, Jianlan ZHENG. The effect of atosiban on premature rupture of membranes in threatened preterm birth and its influence on placental blood perfusion and maternal and infant outcomes[J]. World Clinical Drug, 2025 , 46 (5) : 471 -475 . DOI: 10.13683/j.wph.2025.05.008
Year 2025 volume 46 Issue 5
48
10
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2025.05.008
  • Receive Date:2025-01-03
  • Online Date:2026-11-09
  • Published:2025-05-10
Article Data
Affiliations
History
  • Received:2025-01-03
Affiliations
    Department of Obstetrics, the 73rd Group Military Hospital of the Chinese People's Liberation Army, Xiamen 361001, Fujian Province, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2025.05.008
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT